1. |
Attems J, Jellinger K, Thal DR, et al. Sporadic cerebral amyloid angiopathy. Neuropathol Appl Neurobiol, 2011, 37: 75-93.
|
2. |
Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, et al. Cerebral amyloid angiopathy and Alzheimer disease one peptide, two pathways. Nat Rev Neurol, 2020, 16: 30-42.
|
3. |
Greenberg SM, Vonsattel JP, Stakes JW, et al. The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology, 1993, 43: 2073-2079.
|
4. |
Wermer MJH, Greenberg SM. The growing clinical spectrum of cerebral amyloid angiopathy. Curr Opin Neurol, 2018, 31: 28-35.
|
5. |
Auriel E, Greenberg SM. The pathophysiology and clinical presentation of cerebral amyloid angiopathy. Curr Atheroscler Rep, 2012, 14(4): 343-350.
|
6. |
Charidimou A, Boulouis G, Frosch MP, et al. The Boston criteria version 2. 0 for cerebral amyloid angiopathy:a multicentre, retrospective, MRI neuropathology diagnostic accuracy study. Lancet Neurol, 2022, 21(8): 714-725.
|
7. |
Biffi A, Greenberg SM. Cerebral amyloid angiopathy: a systematic review. J Clin Neurol, 2011, 7(1): 1-9.
|
8. |
Vinters HV. Cerebral amyloid angiopathy. Stroke, 1987, 18(2): 311-324.
|
9. |
Castro Caldas A, Silva C, Albuquerque L, et al. Cerebral amyloid angiopathy associated with inflammation: report of 3 cases and systematic review. J Stroke Cerebrovasc Dis, 2015, 24(9): 2039-2048.
|
10. |
Tabaee Damavandi P, Storti B, Fabin N, et al. Epilepsy in cerebral amyloid angiopathy: an observational retrospective study of a large population. Epilepsia, 2023, 64(2): 500-510.
|
11. |
Chung KK, Anderson NE, Hutchinson D, et al. Cerebral amyloid angiopathy related inflflammation: three case reports and a review. J Neurol Neurosurg Psychiatry, 2011, 82: 20-26.
|
12. |
Fountain NB, Eberhard DA. Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy: report of two cases and review of the literature. Neurology, 1996, 46: 190-197.
|
13. |
Harkness KA, Coles A, Pohl U, et al. Rapidly reversible dementia in cerebral amyloid inflammatory vasculopathy. Eur J Neurol, 2004, 11: 59-62.
|
14. |
Corovic A, Kelly S, Markus HS. Cerebral amyloid angiopathy associated with inflflammation: a systematic review of clinical and imaging features and outcome. Int J Stroke, 2018, 13: 257-267.
|
15. |
DiFrancesco JC, Brioschi M, Brighina L, et al. Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report. Neurology, 2011, 76(9): 842-844.
|
16. |
Piazza F, Greenberg SM, Savoiardo M, et al. Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies. Ann Neurol, 2013, 73(4): 449-458.
|
17. |
Husari KS, Dubey D. Autoimmune epilepsy. Neurotherapeutics, 2019, 16(3): 685-702.
|
18. |
Tolchin B, Fantaneanu T, Miller M, et al. Status epilepticus caused by cerebral amyloid angiopathy-related inflflammation. Epilepsy Behav Case Rep, 2016, 6: 19-22.
|
19. |
Boling W, Kore L. Subarachnoid hemorrhage-related epilepsy. Acta Neurochir Suppl, 2020, 127: 21-25.
|
20. |
Hirano T, Enatsu R, Iihoshi S, et al. Effects of hemosiderosis on epilepsy following subarachnoid hemorrhage. Neurol Med Chir (Tokyo), 2019, 59(1): 27-32.
|
21. |
Greenberg SM, Rapalino O, Frosch MP. Case records of the Massachusetts General Hospital. Case 22-2010. An 87-year-old woman with dementia and a seizure. N Engl J Med, 2010, 22;363(4): 373-81.
|
22. |
Kusakabe K, Inoue A, Matsumoto S, et al. Cerebral amyloid angiopathy-related inflammation with epilepsy mimicking a presentation of brain tumor: a case report and review of the literature. Int J Surg Case Rep, 2018, 48: 95-100.
|
23. |
Alokley AA, Alshamrani FJ, Alabbas FM, et al. When brain biopsy solves the dilemma of diagnosing atypical cerebral amyoild angiopathy: a case report. Am J Case Rep, 2021, 22: e933869.
|
24. |
Neri S, Ascoli M, Africa E, et al. The relevance of MRI blood-sensitive sequences in the diagnostic assessment of late-onset epilepsy. Eur Rev Med Pharmacol Sci, 2022, 26(4): 1178-1182.
|
25. |
Auriel E, Charidimou A, Gurol ME, et al. Validation of clinicoradiological criteria for the diagnosis of cerebral amyloid angiopathy-related inflammation. JAMA Neurol, 2016, 73(2): 197-202.
|
26. |
Antolini L, DiFrancesco JC, Zedde M, et al. Spontaneous ARIA-like events in cerebral amyloid angiopathy-related inflammation: a multicenter prospective longitudinal cohort study. Neurology, 2021, 97(18): e1809-e1822.
|
27. |
Regenhardt RW, Thon JM, Das AS, et al. Association between immunosuppressive treatment and outcomes of cerebral amyloid angiopathyrelated inflammation. JAMA Neurol, 2020, 77(10): 1261-1269.
|
28. |
Martucci M, Sarria S, Toledo M, et al. Cerebral amyloid angiopathy-related inflflammation: imaging fifindings and clinical outcome. Neuroradiology, 2014, 56: 283-289.
|
29. |
Tetsuka S, Hashimoto R. Slightly symptomatic cerebral amyloid angiopathy-related inflflammation with spontaneous remission in four months. Case Rep Neurol Med, 2019, 20: 5308208.
|
30. |
S. Ronsin, G. Deiana, A. F. Geraldo, et al. Pseudotumoral presentation of cerebral amyloid angiopathy-related inflflammation, Neurology, 2016, 86: 912-919.
|
31. |
GBD 2016 Epilepsy Collaborators. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol, 2019, 18(4): 357-375.
|
32. |
DiFrancesco JC, Labate A, Romoli M, et al. Clinical and instrumental characterization of patients with late-onset epilepsy. Front Neurol, 2022, 13: 851897.
|
33. |
Cloyd J, Hauser W, Towne A, et al. Epidemiological and medical aspects of epilepsy in the elderly. Epilepsy Res, 2006, 68(Suppl 1): S39-48.
|
34. |
Bernasconi A, Cendes F, Theodore WH, et al. Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: a consensus report from the International League Against Epilepsy Neuroimaging Task Force, Epilepsia, 2019, 60(5): 1054-1068.
|